+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

Bone Marrow Transplantation Market Report 2025 - Product Thumbnail Image

Bone Marrow Transplantation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
CAR T-cell Therapy Market 2025-2029 - Product Thumbnail Image

CAR T-cell Therapy Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
Cellular Immunotherapy Market Report 2025 - Product Thumbnail Image

Cellular Immunotherapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
Cardiovascular Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 300 Pages
  • Global
From
From
CAR T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Global Market for Stem Cells - Product Thumbnail Image

Global Market for Stem Cells

  • Report
  • March 2023
  • 139 Pages
  • Global
From
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
Loading Indicator